Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical trial developed by consensus of an international study group. Part one: rationale and hypothesis.
Lorenz W, Stinner B, Bauhofer A, Rothmund M, Celik I, Fingerhut A, Koller M, Lorijn RH, Nyström PO, Sitter H, Schein M, Solomkin JS, Troidl H, Wyatt J, Wittmann DH; Lucerne Group for Consensus-assisted Development of the Study Protocol on Prevention of Abdominal Sepsis: Example G-CSF. Lorenz W, et al. Among authors: solomkin js. Inflamm Res. 2001 Mar;50(3):115-22. doi: 10.1007/s000110050734. Inflamm Res. 2001. PMID: 11339498 Clinical Trial.
Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol for a controlled clinical trial developed by consensus of an international study group. Part two: design of the study.
Bauhofer A, Lorenz W, Stinner B, Rothmund M, Koller M, Sitter H, Celik I, Farndon JR, Fingerhut A, Hay JM, Lefering R, Lorijn R, Nyström PO, Schäfer H, Schein M, Solomkin J, Troidl H, Volk HD, Wittmann DH, Wyatt J; Lucerne Group for Consensus-assisted Development of the Study Protocol on Prevention of Abdominal Sepsis: Example G-CSF. Bauhofer A, et al. Inflamm Res. 2001 Apr;50(4):187-205. doi: 10.1007/s000110050744. Inflamm Res. 2001. PMID: 11392607 Review.
Second step: testing-outcome measurements.
Lorenz W, Troidl H, Solomkin JS, Nies C, Sitter H, Koller M, Krack W, Roizen MF. Lorenz W, et al. Among authors: solomkin js. World J Surg. 1999 Aug;23(8):768-80. doi: 10.1007/s002689900578. World J Surg. 1999. PMID: 10415201 Review.
Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group.
Heard SO, Fink MP, Gamelli RL, Solomkin JS, Joshi M, Trask AL, Fabian TC, Hudson LD, Gerold KB, Logan ED. Heard SO, et al. Among authors: solomkin js. Crit Care Med. 1998 Apr;26(4):748-54. doi: 10.1097/00003246-199804000-00027. Crit Care Med. 1998. PMID: 9559614 Clinical Trial.
Antibiotic resistance in postoperative infections.
Solomkin JS. Solomkin JS. Crit Care Med. 2001 Apr;29(4 Suppl):N97-9. doi: 10.1097/00003246-200104001-00008. Crit Care Med. 2001. PMID: 11292883 No abstract available.
198 results